Back to Results
First PageMeta Content
Headaches / Rhinology / Sinusitis / Sinus / Functional endoscopic sinus surgery / Mometasone furoate / Balloon sinuplasty / Nasal polyp / Medicine / Otolaryngology / General practice


Press Release - Propel FDA Approval[removed]FINAL
Add to Reading List

Document Date: 2014-04-17 10:11:22

Open Document

File Size: 114,23 KB

Share Result on Facebook

City

San Francisco / Palo Alto / /

Company

U.S. Venture Partners / Intersect ENT Inc. / Medtronic / /

Country

United States / /

Event

FDA Phase / Funding / /

Facility

University of Pennsylvania Health System / Elwell Court / /

MedicalCondition

headache / sinusitis / Chronic sinusitis / inflammation / facial pain / /

MedicalTreatment

Sinus Surgery / surgery / Head and Neck Surgery / /

Organization

U.S. Food and Drug Administration / University of Pennsylvania Health System in Philadelphia / American Academy / Elwell Court / the University of Pennsylvania / /

Person

David W. Kennedy / Lisa Earnhardt / /

/

Position

president and CEO / professor of Otorhinolaryngology / physician / Otolaryngology-Head / ENT surgeon / /

Product

mometasone furoate / Propel™ / First Drug Releasing / /

ProvinceOrState

Pennsylvania / California / /

Technology

drug delivery / /

URL

www.intersectENT.com / /

SocialTag